Overview
Dr Andrew Thomas, Investment Director at Helvetica Capital and former Global Head, Medicinal 91AV of F Hoffman-La Roche is the fifth recipient of the BMCS Lectureship, awarded by the RSC's Biological and Medicinal 91AV. This is the first in a series of lectures to be delivered throughout the 2018/19 academic year.
Registration
The conference is free to attend, although registration is required. Registration will close on Tuesday, 20th November. Thereafter your name may be added to the waiting list.
Programme
18.00 Registration and light refreshments
18.30 Lecture
20.00 Close and depart
Dr Andrew Thomas, Investment Director at Helvetica Capital and former Global Head, Medicinal 91AV of F Hoffman-La Roche is the fifth recipient of the BMCS Lectureship, awarded by the RSC's Biological and Medicinal 91AV. This is the first in a series of lectures to be delivered throughout the 2018/19 academic year.
Registration
The conference is free to attend, although registration is required. Registration will close on Tuesday, 20th November. Thereafter your name may be added to the waiting list.
Programme
18.00 Registration and light refreshments
18.30 Lecture
20.00 Close and depart
